2m 2m 2m 2m 2m 2m 2m
Haemonetics (HAE)
NYSE
$72.80+$0.27 (+0.37%)
Price as of Jun 23, 2026 4:10 PM EDT- $3.3BMarket Cap
- 0.64%1-Year Change
- Medical DevicesIndustry
Haemonetics (HAE)
$72.80+$0.27 (+0.37%)
Earnings Score
Valuation | HAE | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 1 | ||
Growth | 1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | HAE | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 0.07% | ||
12-Month Momentum | -16.21% | ||
3-Month Risk Adjusted Momentum | 0.39% | ||
12-Month Risk Adjusted Momentum | -31.24% |
True Yield
Valuation | HAE | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 1.16% | ||
Net Debt Paydown Yield | 0.005% |
Financial Health Score
Valuation | HAE | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 6 |